Loading…
A bill to amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products.
Legislative Progress
Introduced
November 14, 2007
Latest Action
November 14, 2007
Primary Sponsor
Charles E. SchumerDemocratic(NY)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2008 · fourth_quarter · Health Issues
S. 2029 - The Physician Payments Sunshine Act of 2007 H.R. 3023 - The Drug and Medical Device Company Gift Disclosure Act of 2007 S. 2313 / H.R. 3697 - The Strategies to Address Antimicrobial Resistance Act of 2007 S. 628 - The Critical Access to Health Information Technology Act of 2007 S. 2351 / H.R. 4200 - A bill to amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products H.R. 3610 - Food and Drug Import Safety Act of 2007 H.R. 3839 - Safeguarding America's Pharmaceuticals Act of 2008 E-Records Patient Safety ERISA Preservation CE bill (Baucus and Allen) - S. 3408 - Comparative Effectiveness Research Act; H.R. 2184 - Enhanced Health Care Value For All Act Wydan bill - S. 334 and H.R. 3163 - Healthy Americans Act and new chron care bill, S. 3613 - Independence At home Act Ryan Tax/Health bill - H.R. 6110 - Roadmap For America's Future Act
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $870,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2008 · fourth_quarter · Health Issues
S. 2029 - The Physician Payments Sunshine Act of 2007 H.R. 3023 - The Drug and Medical Device Company Gift Disclosure Act of 2007 S. 2313 / H.R. 3697 - The Strategies to Address Antimicrobial Resistance Act of 2007 S. 628 - The Critical Access to Health Information Technology Act of 2007 S. 2351 / H.R. 4200 - A bill to amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products. H.R. 3610 - Food and Drug Import Safety Act of 2007 H.R. 3839 - Safeguarding America's Pharmaceuticals Act of 2008 E-Records Patent Safety Erisa Preservation CE bill (Baucus and Allen) - S. 3408 - Comparative Effectiveness Research Act; H.R. 2184 - Enhanced Health Care Value For All Act Wydan bill - S. 334 and H.R. 3163 - Healthy Americans Act; and new chron care bill, S. 3613 - Independence At Home Act. Ryan Tax/Health bill - H.R. 6110 - Roadmap For America's Future Act
Client expense: $740,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2008 · third_quarter · Health Issues
S. 2029 - The Physician Payments Sunshine Act of 2007 H.R. 3023 - The Drug and Medical Device Company Gift Disclosure Act of 2007 S. 2313 / H.R. 3697 - The Strategies to Address Antimicrobial Resistance Act of 2007 S. 628 - The Critical Access to Health Information Technology Act of 2007 S. 2351 / H.R. 4200 - A bill to amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products. H.R. 3610 - Food and Drug Import Safety Act of 2007 H.R. 5839 - Safeguarding America's Pharmaceuticals Act of 2008 E-Records Patient Safety Erisa Preservation CE bill (Baucus and Allen) - S. 3408 - Comparative Effectiveness Research Act; H.R. 2184 - Enhanced Health Care Value For All Act. Wydan bill - S. 334 and H.R. 3163 - Healthy Americans Act; and new chron care bill, S. 3613 - Independence At Home Act. Ryan Tax/Health bill - H.R. 6110 - Roadmap For America's Future Act.
Client expense: $220,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2008 · second_quarter · Health Issues
S. 2029 - The Physician Payments Sunshine Act of 2007. H.R. 3023 - The Drug and Medical Device Company Gift Disclosure Act of 2007. S. 2313 / H.R. 3697 - The Strategies to Address Antimicrobial Resistance Act of 2007. S. 628 - The Critical Access to Health Information Technology Act of 2007. S. 2351 / H.R. 4200 - A bill to amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products Food and Drug Import Safety Act of 2007 - H.R. 3610 Safeguarding America's Pharmaceuticals Act of 2008 - H.R. 5839 E-Records Patient Safety Erisa Preservation
Client expense: $330,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2008 · first_quarter · Health Issues
S. 2029 - The Physician Payments Sunshine Act of 2007. H.R. 3023 - The Drug and Medical Device Company Gift Disclosure Act of 2007. S. 2662 / H.R. 5480 - The Medicare Funding Warning Response Act of 2008. H.R. 3162 - The Children's Health and Medicare Protection Act of 2007. S. 2313 / H.R. 3697 - The Strategies to Address Antimicrobial Resistance Act of 2007. S. 2351 / H.R. 4200 - A bill to amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products. S. 628 - The Critical Access to Health Information Technology Act of 2007. E-Records Patient Safety Medicare Reform Implementation Erisa Preservation
Client expense: $345,159 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), Government Printing Office (GPO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2008 · first_quarter · Taxation/Internal Revenue Code
S. 2351, To amend the Internal Revenue code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products, Issues related to support for medical research into infectious diseases H.R. 4200, To amend the Internal Revenue code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products, Issues related to support for medical research into infectious diseases H.R. 1496, Beating Infections through Research and Development Act of 2007, Issues relating to providing incentives for vaccine research H.R. 2138, Investment in America Act of 2007, To make permanent the research and development tax credit and strengthen the alternative simplified credit S. 2209, Research Credit Improvement Act of 2007, Issues related to research and development tax credit H.R. 1712, Research and Development Tax Credit Act of 2007, Issues related to research and development tax credit
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Science/Technology
Stem Cell Research Small Business Innovation and Research Program (SBIR) H.R. 2720 H.R. 3567 R&D Tax Credit (H.R. 2764) Extension Permanence Alternatives Infectious Disease Tax Credit S. 2351
Client expense: $3,560,000 · Firm income: Not reported
2007 · year_end · Taxation/Internal Revenue Code
Infectious Disease Tax Credit S. 2351 R&D Tax Credit (H.R. 2764) Extension Permanence Alternatives Biobased Products Tax Credits H.R. 2419 H.R. 3586 Biofuels Tax Credits H.R. 2776 H.R. 2419 H.R. 6 S. 2242 H.R. 5890 Carried Interest Tax Treatment Biotech Capital Formation Tax Incentives/Net Operating Losses H.R. 3264: American Life Sciences Competitiveness Act of 2007
Client expense: $3,560,000 · Firm income: Not reported
2007 · year_end · Health Issues
Drug Safety H.R. 3580; H.R. 2900 S. 1082 Medicaid Rebates H.R. 3162 H.R. 2764 S. 2499 Comparative Effectiveness Program Initiatives H.R. 3162; H.R. 2764; H.R. 976; H.R. 3963 S. 2499 Stem Cell Research Drug Importation H.R. 3161 S. 1859 S. 1644 H.R. 2628 H.R. 2764 Funding for Food and Drug Administration (Critical Path Initiative; Human Drug Review) H.R. 3161 S. 1859 H.R. 2764 340B of the Public Health Service Act/Drug Prices for Covered Entitites Coverage of Different Entities S. 2499 FDA Regulatory Processes for First-Time Filers Food & Drug Administration Amendments Act/Food & Drug Administration Revitalization Act (H.R. 3580; H.R. 2900; S. 1082) User Fees/FDA Waivers for Small Businesses Risk Management Plans and Post-market Authorities Clinical Trial Registry and Results Databases Preemption Pharmaceutical Anti-Counterfeiting Priority Review Vouchers for Approved New Tropical Disease Therapies Civil Monetary Penalties FDA Advisory Panels/Conflict of Interest Possible Follow-on Biologics Amendments Follow-on Biologics H.R. 1038 H.R. 1956 S. 1695 S. 623 Presciption Drug User Fees H.R. 3580; H.R. 2900 S. 1082 Vaccines for Children Program H.R. 4990 Vaccines for Uninsured Adults H.R. 4993 National Vaccine Immunization Rates National Vaccine Program Office Working Paper on Adolescent Immunization Influenza Immunization Physician Quality Reporting Inititiative Vaccine Financing National Vaccine Program Office Draft White Paper on Vaccine Financing Vaccines and Medicare Part B/Part D H.R. 4992 Vaccines and Distribution/Shortage Issues H.R. 4991 S. 2456 Funding for Pandemic Influenza H.R. 3043 S. 1710 H.R. 2764 BARDA and Project BioShield HHS Implementation Plans Funding (H.R. 3043; S. 1710; H.R. 2764) Emerging Diseases Regulatory Processes Emergency Use Authorization Genetic Testing Regulatory Oversight Infectious Disease Research Tax Credit S. 2351 Funding for State Children's Health Insurance Program S. 2086; S. 1893; S. 2499 H.R. 3162; H.R. 3963; H.R. 976 Pharmaceutical Anti-Counterfeiting H.R. 3580; H.R. 2900 S. 1082 Erythropiesis Stimulating Agents CMS National Coverage Decision
2007 · year_end · Medical/Disease Research/Clinical Labs
Funding for National Institutes of Health H.R. 3043 S. 1710 H.R. 2764 BARDA and Project BioShield HHS Implementation Plans Funding (H.R. 3043; S.1710; H.R. 2764) Funding for Pandemic Influenza H.R. 3043 S. 1710 H.R. 2764 Critical Path Inititive H.R. 3161 S. 1859 Stem Cell Research Genetic Testing Regulatory Oversight Infectious Disease Reserach Tax Credit S. 2351 Comparative Effectiveness Program Initiatives S. 2499 H.R. 3162; H.R. 2764; H.R. 976; H.R. 3963
Client expense: $3,560,000 · Firm income: Not reported
2007 · year_end · Taxation/Internal Revenue Code
Infectious Disease Tax Credit S. 2351
Client expense: $2,960,000 · Firm income: Not reported
2007 · year_end · Taxation/Internal Revenue Code
H.R. 4200, Amend the Internal Revenue code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products, Issues related to support for medical research S. 2351, Amend the Internal Revenue code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products, Issues related to support for medical research
Client expense: $740,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Medical/Disease Research/Clinical Labs
HR 3697, Strategies to Address Antimicrobial Resistance S 2351, Strategies to Address Antimicrobial Resistance Biosafety for high containment laboratory research - no bill number
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), UNDETERMINED, White House Office
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), UNDETERMINED, White House Office
Client expense: $3,560,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), UNDETERMINED, White House Office
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), UNDETERMINED, White House Office
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office